Company intelligence / Profile preview

Neuome Technologies

Bangalore, Karnataka, Indianeuome.com ↗

Ownership: Private
Development stage: Commercial

Overview

Neuome Technologies develops disruptive biospecimen preservation and diagnostic platforms that eliminate cold chain requirements, reduce costs, and enable rapid point-of-care pathogen detection. Their solutions are designed to support precision medicine through advanced biobanking and secure data analytics. The company emphasizes sustainability, accessibility, and interdisciplinary innovation across genomics, bioinformatics, molecular diagnostics, and biotechnology.

Therapeutic areas: OtherInfectious Diseases
Modalities: Diagnostic platforms (point-of-care diagnostics)Biospecimen preservation technologiesBioinformatics solutions
Industry: Molecular Diagnostics

Partnerships

Engages in collaborations with key players in healthcare/biotech sectors but specific partners are not named publicly.

Beyond the preview

Go deeper on Neuome Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuome Technologies.

Explore the full profile